Billev White Logo
Contact us

Services

Medical Devices and In Vitro Diagnostics

Authorised Representative for medical devices

Image credit: Photo by Tima Miroshnichenko on Pexels

Authorised Representative for medical devices: your gateway to EU market access

Entering the EU market should feel like growth—but for many manufacturers, it quickly turns into regulatory pressure. Without a Authorised Representative for medical devices, your product simply cannot be placed on the EU market if you are based outside the Union. This is not a minor requirement—it is a strict legal obligation under MDR and IVDR.

The problem is that most companies realise this too late. Documentation gaps, delayed CE marking, failed audits, or blocked market entry are common consequences. And when compliance issues arise, the responsibility doesn’t disappear—it escalates. The Authorised Representative is not just a formality; they are legally and operationally linked to your product and its compliance lifecycle.

That’s where the real risk lies. Choosing the wrong partner—or treating this role as a checkbox—can lead to delays, financial losses, and reputational damage. But done right, it becomes a strategic advantage: faster approvals, smoother communication with authorities, and full regulatory control.

Get your Authorised Representative now

How to Reach us?

Billev farmacija vzhod, d. o. o.
Billev Pharma East Ltd.
Tržaška cesta 202

1000 Ljubljana

Slovenia

Contact Us

What companies must do to ensure compliance

If you want to successfully enter and operate in the EU market, appointing an Authorised Representative for medical devices is only the starting point—not the solution.

First, you must formally designate a single Authorised Representative established within the EU through a written mandate. This mandate defines responsibilities and ensures the representative can act on your behalf with authorities.

But beyond the appointment, companies need to ensure that everything behind that role is fully aligned. Your medical device technical file, must be complete, up to date, and fully compliant with MDR/IVDR requirements. The representative will verify this—and authorities will expect it.

You also need to be prepared for ongoing obligations. Compliance does not stop at market entry. Post-market surveillance, vigilance reporting, EUDAMED registration, and continuous communication with authorities are all part of the system.

In practice, this means companies must move from a fragmented, reactive approach to a structured regulatory system. Without that shift, even the right Authorised Representative cannot prevent delays or compliance risks.

How Billev Pharma East acts as your Authorised Representative - and more

This is where Billev Pharma East becomes more than a service provider—acting as a strategic partner in compliance.

Beyond the role of an Authorised Representative for medical devices, this approach combines fully integrated medical device regulatory consulting with a structured regulatory framework that ensures your product is compliant from day one and remains compliant throughout its lifecycle.

ISO 13485 consulting

Our services are delivered by experienced ISO 13485 consultants, providing you with a structured and reliable foundation for regulatory success.

We support you by:

  • Acting as your official Authorised Representative for manufacturers outside the EU
  • Establishing and maintaining your quality management system
  • Preparing and reviewing technical documentation and clinical evaluations
  • Supporting MDR and IVDR transitions, gap analyses, and implementation
  • Managing post-market surveillance, vigilance, and regulatory communication

What makes the difference is integration. Instead of managing multiple vendors, you work with one partner who connects regulatory strategy, documentation, compliance, and lifecycle management into one seamless system.

The result? Faster market access, reduced risk, and full confidence that your compliance is not just achieved—but sustained.

No legal risk. Full MDR compliance support.

What does an Authorised Representative for medical devices actually do?

The role of an Authorised Representative for medical devices is often misunderstood. Many companies assume it is an administrative requirement—but under EU MDR and IVDR, it is a legally defined role with significant responsibility.

An Authorised Representative acts as your official point of contact with EU authorities. This means they are not only listed on your product, but also directly involved in ensuring that your device meets all regulatory requirements before and after it enters the market.

Their responsibilities go far beyond communication. They must verify that your technical documentation and declaration of conformity are complete and compliant, ensure that your product is correctly registered (including in EUDAMED), and cooperate with authorities in case of vigilance issues, audits, or corrective actions.

This is where the real weight of the role becomes clear: liability. Under the MDR, an Authorised Representative can be held jointly and severally liable for defective devices if a non-EU manufacturer fails to meet its regulatory obligations.

In practice, this makes the relationship much more than formal. Your representative becomes an extension of your regulatory system—connecting your internal processes with external regulatory expectations across the entire lifecycle, from market entry to post-market surveillance and vigilance.

That’s why companies that treat this role as a checkbox often run into problems. But those who understand its full scope use it as a control point—ensuring compliance, improving transparency, and enabling faster, safer access to the EU market.

Who needs Medical inquiries support?

Professional support for medical inquiries and medical information service activities is essential for pharmaceutical, biotech, medical device, and healthcare companies that regularly communicate with healthcare professionals, patients, distributors, or regulatory stakeholders. As product portfolios grow and regulatory expectations become more demanding, many organizations struggle to manage every incoming medical inquiry consistently, scientifically, and within required timelines.

This support is especially valuable for companies experiencing rapid portfolio growth, increasing inquiry volumes, expanding pharmacovigilance obligations, or limited internal medical information resources. Organizations involved in pharmacovigilance-intensive products, complex therapies, or specialized medical areas often require additional medical and scientific expertise to respond accurately to healthcare professionals and identify potential adverse events early.

Companies preparing for audits or inspections also increasingly rely on external medical information, medical information service, and pharmacovigilance experts to strengthen documentation processes, improve response consistency, and ensure proper integration between medical information, safety reporting, and regulatory compliance workflows.

Ready to appoint the right Authorised Representative for medical devices?

At this point, the decision is no longer about whether you need an Authorised Representative for medical devices—because under EU MDR, you simply cannot access the market without one. The real question is whether your Authorised Representative will only fulfil the minimum legal requirement—or actively protect your business. Because the risks are real. An Authorised Representative is not just a contact point; they verify your documentation, cooperate with authorities, and can even share legal liability if compliance fails.

That means your choice directly impacts:

  • how fast you enter the EU market
  • how well you handle audits and inspections
  • how safely you manage complaints, vigilance, and regulatory updates
  • and ultimately, whether your product remains on the market

Companies that treat this as a checkbox often face delays, rework, or regulatory exposure. But companies that choose a partner with a fully integrated approach gain something much more valuable: control, predictability, and speed. That’s exactly what we deliver at Billev Pharma East.

We don’t just act as your Authorised Representative for medical devices—we take responsibility for making your entire regulatory system work. From documentation to lifecycle compliance, you get one partner aligned with your success in the EU market.

If you’re preparing for EU market entry—or already facing regulatory pressure—this is the moment to act.

Get in touch and secure a compliant, reliable, and scalable Authorised Representative today.

More ways,
we can help.

With a focus on expert guidance and strategic insights, we propel your projects forward with confidence, ensuring every step is handled with precision.

Need any consultancy?

Contact Us

Don’t miss out

Follow us on LinkedIn

Follow Us

Watch our
promotional video

Watch on YouTube

Regulatory Affairs

Pharmacovigilance

Medical Consultancy

Medical Affairs

Quality/GxP

Digital Consultancy

Medical Devices and In Vitro Diagnostics

Contact Us
logo-billev-pharma-east

HOME

SERVICES

Regulatory Affairs

PharmacoVigilance

Medical Consultancy

Quality / GxP

Digital Consultancy

TEAM OF EXPERTS

ABOUT US

NEWS AND EVENTS

B2B PARTNER LOG-IN

CONTACT

billeveast@billeveast.com

+386 123 22095

Tržaška cesta 202
1000 Ljubljana
Slovenia

FOLLOW US